Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05816603 · ClinicalTrials.gov registry record · Phase 2
Transcranial Direct Current Stimulation for Post-stroke Fatigue
A Phase 2 study of Fatigue and Stroke Rehabilitaion, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05816603: Recruiting Phase 2 study of Fatigue and Stroke Rehabilitaion, sponsored by Weill Medical College of Cornell University.
NCT05816603 is a Phase 2 study of Fatigue and Stroke Rehabilitaion that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 24 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05816603, a Phase 2 study of Fatigue and Stroke Rehabilitaion, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that delivery of anodal tDCS to the left frontal head region will reduce fatigue severity following stroke.
Primary Outcome
Fatigue Severity. This seven item scale measures fatigue severity and it's effect on a person's lifestyle and activities. Items are scored on a seven point scale. Minimum score = 7, maximum score = 49 with higher score indicating greater fatigue severity.
Conditions Studied
Interventions
- DEVICE Real Soterix Mini-CT tDCS stimulator
- DEVICE Sham Soterix Mini-CT tDCS stimulator
Study Locations (1)
New York
- Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106 - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-05-23 |
| Est. Completion | 2027-12 |
| Phase | Phase 2 |
What NCT05816603 shows while recruiting
NCT05816603 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Fatigue appearing as the primary indexed condition, and to 2 interventions - of which Real Soterix Mini-CT tDCS stimulator is the first listed.
NCT05816603 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05816603 about?
NCT05816603 is a clinical study titled "Transcranial Direct Current Stimulation for Post-stroke Fatigue". The investigators hypothesize that delivery of anodal tDCS to the left frontal head region will reduce fatigue severity following stroke.
What is the current status of trial NCT05816603?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2023-05-23. Estimated completion is 2027-12.
What conditions does trial NCT05816603 study?
This clinical trial studies the following conditions: Fatigue, Stroke Rehabilitaion.
What interventions are being tested in trial NCT05816603?
The interventions under investigation include: Real Soterix Mini-CT tDCS stimulator (DEVICE), Sham Soterix Mini-CT tDCS stimulator (DEVICE).
Who is sponsoring clinical trial NCT05816603?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05816603 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05816603's enrollment target sits among peer trials
24 91st of 109 higher than 16 of 109 other Fatigue trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fatigue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
RECRUITING · Phase 2
-
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
RECRUITING · Phase 2
-
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
RECRUITING · Phase 2
-
Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer
RECRUITING · Phase 2
-
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI